NCT04699292Recruiting
International Prospective Registry on Local Treatment Approaches in MLS
International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
Source: ClinicalTrials.gov · Last updated 30 Aug 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 6 Jan 2021
- Start date
- 18 Jan 2021
- Primary completion date
- Jan 2031
- Lead sponsor
- The Netherlands Cancer Institute
- Diseases
- Sarcoma
- NCT number
- NCT04699292
What you commit to
- Study type: Observational
- Planned participants: 300
- From 18 Jan 2021 to the primary completion date, Jan 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior radiotherapy to the target area
Other
- Pregnancy
Who the study is looking for
- Age \> 18 years
- Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
- ECOG PS 0-2
- Written informed consent to share coded information in this international Registry
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Netherlands Cancer Institute Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.